Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Windtree Therapeutics - 30 Year Stock Price History | WINT

Historical daily share price chart and data for Windtree Therapeutics since 1995 adjusted for splits and dividends. The latest closing stock price for Windtree Therapeutics as of November 14, 2025 is 0.07.
  • The all-time high Windtree Therapeutics stock closing price was 1000000.00 on August 07, 1995.
  • The Windtree Therapeutics 52-week high stock price is 31.00, which is 44185.7% above the current share price.
  • The Windtree Therapeutics 52-week low stock price is 0.06, which is 14.3% below the current share price.
  • The average Windtree Therapeutics stock price for the last 52 weeks is 4.34.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Windtree Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 2.0827 17.0000 17.0000 0.0600 0.0650 -99.63%
2024 235.9881 630.0000 630.0000 15.0000 17.5000 -97.30%
2023 2668.1760 8100.0000 11250.0000 648.0000 648.0000 -91.53%
2022 27073.5060 72000.0000 72000.0000 7200.0000 7650.0000 -89.44%
2021 118737.5000 229500.0000 278100.0000 63000.0000 72450.0000 -68.62%
2020 375529.4466 573750.0000 600750.0000 148500.0000 230850.0000 -59.76%
2019 546578.5714 675000.0000 722250.0000 357750.0000 573750.0000 -15.00%
2018 498859.9602 687150.0000 784350.0000 341550.0000 675000.0000 19.05%
2017 814683.4661 1000000.0000 1000000.0000 486000.0000 567000.0000 -43.30%
2016 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
2015 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
2014 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
2013 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
2012 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
2011 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
2010 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
2009 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
2008 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
2007 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
2006 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
2005 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
2004 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
2003 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
2002 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
2001 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
2000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
1999 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
1998 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
1997 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
1996 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.002B $0.000B
Windtree Therapeutics, Inc. is a biotechnology company focused on developing novel surfactant therapies for respiratory diseases and other potential applications. The company's proprietary technology platform includes a synthetic, peptide-containing surfactant that is structurally similar to endogenous pulmonary surfactant and novel drug-delivery technologies being developed to enable noninvasive administration of aerosolized KL4 surfactant. Windtree Therapeutics, Inc., formerly known as Discovery Laboratories Inc., is based in Warrington, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $181.328B 15.40
Gilead Sciences (GILD) United States $155.110B 15.27
Vertex Pharmaceuticals (VRTX) United States $110.913B 28.55
GSK (GSK) United Kingdom $95.795B 10.65
Bristol Myers Squibb (BMY) United States $94.968B 7.11
Regeneron Pharmaceuticals (REGN) United States $72.886B 18.91
Alnylam Pharmaceuticals (ALNY) United States $59.340B 1952.87
CSL (CSLLY) Australia $57.093B 0.00
Insmed (INSM) United States $41.209B 0.00
Novozymes (NVZMY) Denmark $30.168B 0.00
BioNTech SE (BNTX) Germany $24.789B 0.00
Royalty Pharma (RPRX) United States $22.605B 8.66
Incyte (INCY) United States $20.447B 19.58
Genmab (GNMSF) Denmark $20.087B 14.74
Genmab (GMAB) Denmark $19.429B 14.62
Illumina (ILMN) United States $18.438B 27.68
Roivant Sciences (ROIV) United Kingdom $13.856B 0.00
Revolution Medicines (RVMD) United States $13.097B 0.00
Exact Sciences (EXAS) United States $12.700B 352.79
Guardant Health (GH) United States $11.895B 0.00
Exelixis (EXEL) United States $11.167B 17.88
Avidity Biosciences (RNA) United States $10.668B 0.00
BioMarin Pharmaceutical (BMRN) United States $10.514B 19.07
QIAGEN (QGEN) Netherlands $9.852B 18.70
Moderna (MRNA) United States $9.678B 0.00
Bio-Techne Corp (TECH) United States $9.252B 34.52
Abivax SA (ABVX) France $8.592B 0.00
Repligen (RGEN) United States $8.577B 91.79
Jazz Pharmaceuticals (JAZZ) Ireland $8.572B 33.43
Halozyme Therapeutics (HALO) United States $8.235B 13.16
Cytokinetics (CYTK) United States $8.123B 0.00
Merus (MRUS) Netherlands $7.278B 0.00
Nuvalent (NUVL) United States $7.016B 0.00
Cidara Therapeutics (CDTX) United States $6.845B 0.00
Rhythm Pharmaceuticals (RYTM) United States $6.634B 0.00
Vaxcyte (PCVX) United States $6.374B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $6.231B 0.00
PTC Therapeutics (PTCT) United States $6.046B 8.21
Krystal Biotech (KRYS) United States $5.978B 30.91
Zealand Pharma (ZLDPF) Denmark $5.717B 5.79
Legend Biotech (LEGN) United States $5.591B 0.00
Protagonist Therapeutics (PTGX) United States $5.289B 136.47
Arcellx (ACLX) United States $5.203B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.006B 0.00
TG Therapeutics (TGTX) United States $4.922B 11.15
Alkermes (ALKS) Ireland $4.795B 14.10
Cogent Biosciences (COGT) United States $4.775B 0.00
Kymera Therapeutics (KYMR) United States $4.672B 0.00
Praxis Precision Medicines (PRAX) United States $4.662B 0.00
Akero Therapeutics (AKRO) United States $4.466B 0.00
Viking Therapeutics (VKTX) United States $4.421B 0.00
Celcuity (CELC) United States $4.288B 0.00
Immunovant (IMVT) United States $4.161B 0.00
Belite Bio (BLTE) United States $4.072B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.064B 34.31
Ligand Pharmaceuticals (LGND) United States $3.953B 97.03
Anbio Biotechnology (NNNN) Germany $3.744B 0.00
ADMA Biologics Inc (ADMA) United States $3.703B 26.37
Mirum Pharmaceuticals (MIRM) United States $3.672B 0.00
Scholar Rock Holding (SRRK) United States $3.596B 0.00
Disc Medicine (IRON) United States $3.396B 0.00
Mineralys Therapeutics (MLYS) United States $3.233B 0.00
Ascentage Pharma Group - (AAPG) China $3.201B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.191B 0.00
Telix Pharmaceuticals (TLX) Australia $3.164B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.150B 0.00
CG Oncology (CGON) United States $3.127B 0.00
GRAIL (GRAL) United States $3.104B 0.00
Tarsus Pharmaceuticals (TARS) United States $3.095B 0.00
Travere Therapeutics (TVTX) United States $3.087B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $3.056B 89.60
Apogee Therapeutics (APGE) United States $3.020B 0.00
Amicus Therapeutics (FOLD) United States $2.925B 237.00
Jyong Biotech (MENS) Taiwan $2.904B 0.00
IDEAYA Biosciences (IDYA) United States $2.818B 0.00
Viridian Therapeutics (VRDN) United States $2.746B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.630B 0.00
Apellis Pharmaceuticals (APLS) United States $2.572B 65.58
Denali Therapeutics (DNLI) United States $2.558B 0.00
Agios Pharmaceuticals (AGIO) United States $2.545B 0.00
Liquidia (LQDA) United States $2.439B 0.00
Zai Lab (ZLAB) China $2.431B 0.00
Edgewise Therapeutics (EWTX) United States $2.409B 0.00
Arcus Biosciences (RCUS) United States $2.167B 0.00
Bavarian Nordic (BVNRY) Denmark $2.161B 5.86
Recursion Pharmaceuticals (RXRX) United States $2.155B 0.00
Adaptive Biotechnologies (ADPT) United States $2.153B 0.00
Structure Therapeutics (GPCR) United States $2.128B 0.00
ImmunityBio (IBRX) United States $2.049B 0.00
Terns Pharmaceuticals (TERN) United States $2.032B 0.00
Vericel (VCEL) United States $2.016B 166.08
Sarepta Therapeutics (SRPT) United States $1.971B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.960B 10.70
Mesoblast (MESO) Australia $1.895B 0.00
ANI Pharmaceuticals (ANIP) United States $1.888B 14.64
Zenas BioPharma (ZBIO) United States $1.879B 0.00
UniQure (QURE) Netherlands $1.861B 0.00
Spyre Therapeutics (SYRE) United States $1.823B 0.00
Vera Therapeutics (VERA) United States $1.812B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.811B 0.00
Janux Therapeutics (JANX) United States $1.761B 0.00
Dianthus Therapeutics (DNTH) United States $1.751B 0.00
Precigen (PGEN) United States $1.716B 0.00
Celldex Therapeutics (CLDX) United States $1.698B 0.00
Nuvation Bio (NUVB) United States $1.666B 0.00
Alvotech (ALVO) Luxembourg $1.655B 23.87
Sionna Therapeutics (SION) United States $1.651B 0.00
Twist Bioscience (TWST) United States $1.622B 0.00
Immunome (IMNM) United States $1.572B 0.00
Maze Therapeutics (MAZE) United States $1.565B 0.00
MannKind (MNKD) United States $1.554B 50.60
Stoke Therapeutics (STOK) United States $1.514B 39.57
Trevi Therapeutics (TRVI) United States $1.458B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.445B 0.00
Zymeworks (ZYME) United States $1.386B 0.00
NeoGenomics (NEO) United States $1.338B 0.00
Certara (CERT) United States $1.327B 24.50
Upstream Bio (UPB) United States $1.326B 0.00
Dynavax Technologies (DVAX) United States $1.299B 38.14
NovoCure (NVCR) Jersey $1.268B 0.00
Immatics (IMTX) Germany $1.240B 0.00
Pharvaris (PHVS) Netherlands $1.231B 0.00
Oric Pharmaceuticals (ORIC) United States $1.193B 0.00
CureVac (CVAC) Germany $1.185B 5.50
WAVE Life Sciences (WVE) Singapore $1.184B 0.00
Rapport Therapeutics (RAPP) United States $1.162B 0.00
Pharming Group (PHAR) Netherlands $1.152B 0.00
Inhibrx Biosciences (INBX) United States $1.146B 0.00
Novavax (NVAX) United States $1.133B 2.88
Mind Medicine (MindMed) (MNMD) United States $1.118B 0.00
MBX Biosciences (MBX) United States $1.113B 0.00
Urogen Pharma (URGN) United States $1.112B 0.00
AbCellera Biologics (ABCL) Canada $1.105B 0.00
Tango Therapeutics (TNGX) United States $1.100B 0.00
MiMedx (MDXG) United States $1.093B 19.42
Sana Biotechnology (SANA) United States $1.063B 0.00
Septerna (SEPN) United States $1.042B 0.00
Phathom Pharmaceuticals (PHAT) United States $1.036B 0.00
Kodiak Sciences (KOD) United States $1.035B 0.00
Pharming Group (PHGUF) Netherlands $1.027B 153.00
Oculis Holding AG (OCS) Switzerland $1.027B 0.00
Pacira BioSciences (PCRX) United States $1.023B 11.71
Intellia Therapeutics (NTLA) United States $1.008B 0.00
Nanobiotix S.A - (NBTX) France $0.997B 0.00
Palvella Therapeutics (PVLA) United States $0.991B 0.00
Nurix Therapeutics (NRIX) United States $0.984B 0.00
Iovance Biotherapeutics (IOVA) United States $0.981B 0.00
Castle Biosciences (CSTL) United States $0.976B 133.80
Kura Oncology (KURA) United States $0.975B 0.00
Fortrea Holdings (FTRE) United States $0.962B 20.41
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.959B 0.00
AnaptysBio (ANAB) United States $0.936B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.935B 44.88
Oxford BioMedica (OXBDF) United Kingdom $0.922B 0.00
Rezolute (RZLT) United States $0.915B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.904B 0.00
CorMedix Inc (CRMD) United States $0.886B 8.20
Arbutus Biopharma (ABUS) United States $0.869B 0.00
Compass Therapeutics (CMPX) United States $0.859B 0.00
Tyra Biosciences (TYRA) United States $0.840B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $0.820B 0.00
LENZ Therapeutics (LENZ) United States $0.801B 0.00
Rapt Therapeutics (RAPT) United States $0.799B 0.00
Vir Biotechnology (VIR) United States $0.783B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.781B 0.00
Gyre Therapeutics (GYRE) United States $0.770B 99.88
Erasca (ERAS) United States $0.732B 0.00
GH Research (GHRS) Ireland $0.728B 0.00
Geron (GERN) United States $0.715B 0.00
Replimune (REPL) United States $0.705B 0.00
Cytek Biosciences (CTKB) United States $0.703B 0.00
Ventyx Biosciences (VTYX) United States $0.660B 0.00
MeiraGTx Holdings (MGTX) United States $0.659B 0.00
CytomX Therapeutics (CTMX) United States $0.657B 9.70
Corvus Pharmaceuticals (CRVS) United States $0.655B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Gossamer Bio (GOSS) United States $0.627B 0.00
Myriad Genetics (MYGN) United States $0.625B 0.00
Prime Medicine (PRME) United States $0.608B 0.00
MapLight Therapeutics (MPLT) United States $0.584B 0.00
Opthea (OPT) Australia $0.583B 0.00
REGENXBIO (RGNX) United States $0.583B 0.00
Olema Pharmaceuticals (OLMA) United States $0.577B 0.00
Alumis (ALMS) United States $0.574B 0.00
Inventiva S.A (IVA) France $0.557B 0.00
Evommune (EVMN) $0.550B 0.00
Niagen Bioscience (NAGE) United States $0.548B 42.94
Invivyd (IVVD) United States $0.548B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.541B 0.00
Prothena (PRTA) Ireland $0.535B 0.00
Emergent Biosolutions (EBS) United States $0.531B 5.11
Keros Therapeutics (KROS) United States $0.526B 11.21
Monopar Therapeutics (MNPR) United States $0.521B 0.00
Cullinan Therapeutics (CGEM) United States $0.505B 0.00
Verastem (VSTM) United States $0.504B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.491B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.487B 0.00
NovaBridge Biosciences (NBP) United States $0.478B 0.00
Fulcrum Therapeutics (FULC) United States $0.468B 0.00
Eton Pharmaceuticals (ETON) United States $0.454B 0.00
Bright Minds Biosciences (DRUG) United States $0.451B 0.00
DBV Technologies S.A (DBVT) France $0.448B 0.00
Neumora Therapeutics (NMRA) United States $0.443B 0.00
EnGene Holdings (ENGN) Canada $0.437B 0.00
Absci (ABSI) United States $0.424B 0.00
Design Therapeutics (DSGN) United States $0.420B 0.00
XOMA Royalty (XOMA) United States $0.404B 0.00
Kamada (KMDA) Israel $0.402B 19.42
PureTech Health (PRTC) United States $0.391B 0.00
LB Pharmaceuticals Inc (LBRX) United States $0.377B 0.00
Alto Neuroscience (ANRO) United States $0.376B 0.00
Ocugen (OCGN) United States $0.372B 0.00
Northwest Biotherapeutics (NWBO) United States $0.370B 0.00
Neurogene (NGNE) United States $0.353B 0.00
Jade Biosciences (JBIO) United States $0.349B 0.00
Tectonic Therapeutic (TECX) United States $0.347B 0.00
Benitec Biopharma (BNTC) United States $0.345B 0.00
Amarin (AMRN) Ireland $0.340B 0.00
Entrada Therapeutics (TRDA) United States $0.334B 0.00
AC Immune (ACIU) Switzerland $0.330B 0.00
Solid Biosciences (SLDB) United States $0.330B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.330B 0.00
Annexon (ANNX) United States $0.324B 0.00
X4 Pharmaceuticals (XFOR) United States $0.320B 0.00
Palisade Bio (PALI) United States $0.319B 0.00
Contineum Therapeutics (CTNM) United States $0.311B 0.00
DiaMedica Therapeutics (DMAC) United States $0.309B 0.00
Kyverna Therapeutics (KYTX) United States $0.301B 0.00
Lifecore Biomedical (LFCR) United States $0.298B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.283B 0.00
Allogene Therapeutics (ALLO) United States $0.276B 0.00
Prima BioMed (IMMP) Australia $0.272B 0.00
Zura Bio (ZURA) United States $0.265B 0.00
Foghorn Therapeutics (FHTX) United States $0.265B 0.00
Immuneering (IMRX) United States $0.264B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.258B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.257B 0.00
Candel Therapeutics (CADL) United States $0.255B 0.00
Editas Medicine (EDIT) United States $0.254B 0.00
Sagimet Biosciences (SGMT) United States $0.252B 0.00
Puma Biotechnology (PBYI) United States $0.246B 6.61
Abeona Therapeutics (ABEO) United States $0.241B 3.94
C4 Therapeutics (CCCC) United States $0.239B 0.00
Alpha Teknova (TKNO) United States $0.238B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.236B 0.00
Rani Therapeutics Holdings (RANI) United States $0.228B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.228B 0.00
Nautilus Biotechnology (NAUT) United States $0.227B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.222B 0.00
Cabaletta Bio (CABA) United States $0.222B 0.00
Tenaya Therapeutics (TNYA) United States $0.221B 0.00
Adherex Technologies (FENC) United States $0.221B 0.00
Voyager Therapeutics (VYGR) United States $0.219B 0.00
Aardvark Therapeutics (AARD) United States $0.216B 0.00
Adocia (ADOCY) France $0.216B 0.00
GENFIT S.A (GNFT) France $0.213B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.205B 0.00
SELLAS Life Sciences (SLS) United States $0.204B 0.00
Genelux (GNLX) United States $0.202B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.201B 0.00
Humacyte (HUMA) United States $0.195B 0.00
Cartesian Therapeutics (RNAC) United States $0.194B 0.00
CAMP4 Therapeutics (CAMP) United States $0.192B 0.00
Caribou Biosciences (CRBU) United States $0.186B 0.00
Crescent Biopharma (CBIO) United States $0.181B 0.00
Forte Biosciences (FBRX) United States $0.175B 0.00
Molecular Partners AG (MOLN) Switzerland $0.170B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.170B 0.00
MaxCyte (MXCT) United States $0.169B 0.00
Innate Pharma S.A (IPHA) France $0.168B 0.00
Elicio Therapeutics (ELTX) United States $0.156B 0.00
PepGen (PEPG) United States $0.155B 0.00
Nuvectis Pharma (NVCT) United States $0.154B 0.00
Seres Therapeutics (MCRB) United States $0.151B 0.00
VistaGen Therapeutics (VTGN) United States $0.150B 0.00
Sangamo Therapeutics (SGMO) United States $0.150B 0.00
Codexis (CDXS) United States $0.149B 0.00
Agenus (AGEN) United States $0.148B 0.00
Compugen (CGEN) Israel $0.146B 0.00
Anika Therapeutics (ANIK) United States $0.144B 0.00
Coherus Oncology (CHRS) United States $0.144B 0.00
Cardiff Oncology (CRDF) United States $0.143B 0.00
Immix Biopharma (IMMX) United States $0.141B 0.00
Mersana Therapeutics (MRSN) United States $0.139B 0.00
Actuate Therapeutics (ACTU) United States $0.137B 0.00
Cognition Therapeutics (CGTX) United States $0.137B 0.00
Inovio Pharmaceuticals (INO) United States $0.137B 0.00
Spero Therapeutics (SPRO) United States $0.136B 0.00
Alector (ALEC) United States $0.135B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.135B 0.00
Scilex Holding (SCLX) United States $0.134B 0.00
Nkarta (NKTX) United States $0.133B 0.00
Opus Genetics (IRD) United States $0.130B 0.00
Climb Bio (CLYM) United States $0.130B 0.00
Alpha Cognition (ACOG) Canada $0.129B 0.00
EXoZymes (EXOZ) United States $0.128B 0.00
Entera Bio (ENTX) Israel $0.124B 0.00
Coya Therapeutics (COYA) United States $0.123B 0.00
VTv Therapeutics (VTVT) United States $0.121B 0.00
Shattuck Labs (STTK) United States $0.119B 0.00
Connect Biopharma Holdings (CNTB) United States $0.119B 0.00
Turn Therapeutics (TTRX) United States $0.118B 0.00
Greenwich LifeSciences (GLSI) United States $0.115B 0.00
Leap Therapeutics (CYPH) United States $0.114B 0.00
Seer (SEER) United States $0.112B 0.00
Fate Therapeutics (FATE) United States $0.111B 0.00
Starpharma Holdings (SPHRY) Australia $0.110B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.105B 0.00
TuHURA Biosciences (HURA) United States $0.105B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.105B 0.00
Citius Oncology (CTOR) United States $0.104B 0.00
Oncolytics Biotech (ONCY) Canada $0.104B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.104B 0.00
Pliant Therapeutics (PLRX) United States $0.103B 0.00
Kalaris Therapeutics (KLRS) United States $0.102B 0.00
Adicet Bio (ACET) United States $0.102B 0.00
Whitehawk Therapeutics (WHWK) United States $0.101B 0.00
Instil Bio (TIL) United States $0.098B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.096B 0.00
Adverum Biotechnologies (ADVM) United States $0.095B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.094B 0.00
Immunic (IMUX) United States $0.094B 0.00
Quince Therapeutics (QNCX) United States $0.094B 0.00
Ovid Therapeutics (OVID) United States $0.093B 0.00
InflaRx (IFRX) Germany $0.091B 0.00
Biomea Fusion (BMEA) United States $0.091B 0.00
Chrome Holding (MEHCQ) United States $0.090B 0.00
Clene (CLNN) United States $0.088B 0.00
Adagene (ADAG) China $0.086B 0.00
Estrella Immunopharma (ESLA) United States $0.086B 0.00
OKYO Pharma (OKYO) $0.084B 0.00
BeyondSpring (BYSI) United States $0.084B 0.00
Tevogen Bio Holdings (TVGN) United States $0.082B 0.00
XBiotech (XBIT) United States $0.080B 0.00
Fortress Biotech (FBIO) United States $0.078B 0.00
Precision BioSciences (DTIL) United States $0.078B 0.00
Sutro Biopharma (STRO) United States $0.077B 0.00
ALX Oncology Holdings (ALXO) United States $0.075B 0.00
CervoMed (CRVO) United States $0.071B 0.00
ABVC BioPharma (ABVC) United States $0.071B 0.00
Repare Therapeutics (RPTX) Canada $0.071B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.070B 0.00
Oncobiologics (OTLK) United States $0.070B 0.00
Vor Biopharma (VOR) $0.069B 0.00
BioStem Technologies (BSEM) $0.067B 4.68
Equillium (EQ) United States $0.063B 0.00
TScan Therapeutics (TCRX) United States $0.062B 0.00
Annovis Bio (ANVS) United States $0.062B 0.00
MiNK Therapeutics (INKT) United States $0.059B 0.00
Adlai Nortye (ANL) Cayman Islands $0.058B 0.00
Spruce Biosciences (SPRB) United States $0.053B 0.00
Cue Biopharma (CUE) United States $0.050B 0.00
Kezar Life Sciences (KZR) United States $0.045B 0.00
Werewolf Therapeutics (HOWL) United States $0.045B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.043B 0.00
CalciMedica (CALC) United States $0.043B 0.00
Grace Therapeutics (GRCE) Canada $0.043B 0.00
OnKure Therapeutics (OKUR) United States $0.042B 0.00
Senti Biosciences (SNTI) United States $0.042B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.042B 0.00
Skye Bioscience (SKYE) United States $0.042B 0.00
Genenta Science S.p.A (GNTA) Italy $0.042B 0.00
Celularity (CELU) United States $0.041B 0.00
PDS Biotechnology (PDSB) United States $0.041B 0.00
Aligos Therapeutics (ALGS) United States $0.041B 0.00
Radiopharm Theranostics - (RADX) Australia $0.041B 0.00
TELA Bio (TELA) United States $0.040B 0.00
Medicus Pharma (MDCX) United States $0.039B 0.00
Tvardi Therapeutics (TVRD) United States $0.038B 0.00
Lantern Pharma (LTRN) United States $0.038B 0.00
INmune Bio (INMB) United States $0.038B 0.00
Xilio Therapeutics (XLO) United States $0.037B 0.00
Generation Bio (GBIO) United States $0.037B 0.00
Pluri (PLUR) Israel $0.036B 0.00
Galecto (GLTO) Denmark $0.036B 0.00
Hyperion DeFi (HYPD) United States $0.035B 0.00
SAB Biotherapeutics (SABS) United States $0.034B 0.00
Dyadic (DYAI) United States $0.033B 0.00
ImageneBio (IMA) United States $0.033B 0.00
Barinthus Biotherapeutics (BRNS) United States $0.032B 0.00
Tenax Therapeutics (TENX) United States $0.032B 0.00
Elutia (ELUT) United States $0.032B 0.00
Applied Therapeutics (APLT) United States $0.032B 0.00
AN2 Therapeutics (ANTX) United States $0.031B 0.00
Femasys (FEMY) United States $0.029B 0.00
Rein Therapeutics (RNTX) United States $0.029B 0.00
Passage Bio (PASG) United States $0.028B 0.00
Quantum Biopharma (QNTM) Canada $0.028B 0.00
Boundless Bio (BOLD) United States $0.028B 0.00
RenovoRx (RNXT) United States $0.027B 0.00
Jasper Therapeutics (JSPR) United States $0.027B 0.00
Apollomics (APLM) United States $0.027B 0.00
Rallybio (RLYB) United States $0.027B 0.00
Dare Bioscience (DARE) United States $0.027B 0.00
Q32 Bio (QTTB) United States $0.027B 0.00
NextCure (NXTC) United States $0.026B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.026B 0.00
Intensity Therapeutics (INTS) United States $0.026B 0.00
BioXcel Therapeutics (BTAI) United States $0.026B 0.00
IBio (IBIO) United States $0.026B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.025B 0.00
Cadrenal Therapeutics (CVKD) United States $0.024B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.024B 0.00
Exicure (XCUR) United States $0.024B 0.00
Cingulate (CING) United States $0.024B 0.00
Lexaria Bioscience (LEXX) Canada $0.024B 0.00
Synaptogenix (TAOX) United States $0.023B 0.00
Tharimmune (THAR) United States $0.022B 0.00
Moleculin Biotech (MBRX) United States $0.022B 0.00
Promis Neurosciences (PMN) Canada $0.021B 0.00
Clearside Biomedical (CLSD) United States $0.020B 0.00
Synlogic (SYBX) United States $0.020B 0.00
FibroBiologics (FBLG) United States $0.019B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.019B 0.00
Lisata Therapeutics (LSTA) United States $0.019B 0.00
Hoth Therapeutics (HOTH) United States $0.018B 0.00
Curis (CRIS) United States $0.017B 0.00
Allarity Therapeutics (ALLR) United States $0.017B 0.00
MetaVia (MTVA) United States $0.017B 0.00
NewcelX (NCEL) Switzerland $0.016B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.015B 0.00
Abpro Holdings (ABP) United States $0.015B 0.00
Longeveron (LGVN) United States $0.015B 0.00
Revelation Biosciences (REVB) United States $0.014B 0.00
Soligenix (SNGX) United States $0.014B 0.00
Chemomab Therapeutics (CMMB) Israel $0.014B 0.00
GeoVax Labs (GOVX) United States $0.013B 0.00
Imunon (IMNN) United States $0.013B 0.00
Dogwood Therapeutics (DWTX) United States $0.013B 0.00
Edesa Biotech (EDSA) Canada $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.011B 0.00
Beyond Air (XAIR) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Cocrystal Pharma (COCP) United States $0.011B 0.00
Novogen (KZIA) Australia $0.010B 0.00
Sensei Biotherapeutics (SNSE) United States $0.010B 0.00
Propanc Biopharma Inc (PPCB) Australia $0.010B 0.00
Acurx Pharmaceuticals (ACXP) $0.010B 0.00
Advanced Biomed (ADVB) United States $0.009B 0.00
Gelteq (GELS) Australia $0.009B 0.00
Purple Biotech (PPBT) Israel $0.009B 0.00
Mustang Bio (MBIO) United States $0.009B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.009B 0.00
Bolt Biotherapeutics (BOLT) United States $0.009B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.008B 0.00
Sunshine Biopharma (SBFM) United States $0.008B 0.00
Adial Pharmaceuticals (ADIL) United States $0.008B 0.00
Mainz Biomed (MYNZ) Germany $0.008B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
Avalon GloboCare (ALBT) United States $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Evogene (EVGN) Israel $0.006B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
Bionano Genomics (BNGO) United States $0.006B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Entero Therapeutics (ENTO) United States $0.006B 0.00
VivoSim Labs (VIVS) United States $0.006B 0.00
GENPREX (GNPX) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Cyclerion Therapeutics (CYCN) United States $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Arcadia Biosciences (RKDA) United States $0.005B 0.00
Psyence Biomedical (PBM) Canada $0.005B 0.00
KALA BIO (KALA) United States $0.005B 0.00
Polyrizon (PLRZ) Israel $0.005B 0.00
Black Titan (BTTC) United States $0.004B 0.00
GRI Bio (GRI) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
GT Biopharma (GTBP) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Alps Group (ALPS) United States $0.003B 2.35
Virax Biolabs Group (VRAX) United Kingdom $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Cellectis S.A (CLLS) France $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
IO Biotech (IOBT) Denmark $0.000B 0.00
MediciNova (MNOV) United States $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
YD Bio (YDES) $0.000B 0.00